-
Happiest Health Announces Launch of Speciality Clinics: Happiest Paediatrics, Happiest Orthopaedics, Happiest Gynaecology, Happiest Endocrinology & Your Personal Physician
BENGALURU, India, July 9, 2026 /PRNewswire/ — Happiest Health is happy to announce the launch of Speciality Clinics, Happiest Paediatrics, Happiest Orthopaedics, Happiest Gynaecology, Happiest Endocrinology & Your Personal Physician in Koramangala, Bengaluru, marking its entry into neighbourhood healthcare. This represents a significant expansion of the company’s healthcare ecosystem, bringing consultations, diagnostics, and pharmacy services together…
-
Menarini Group Reports Data from the Phase 3 SENTRY Trial of Selinexor Plus Ruxolitinib in Myelofibrosis at The European Hematology Association (EHA) 2026 Congress
The combination of selinexor plus ruxolitinib met the first co-primary endpoint demonstrating a statistically significant improvement of spleen volume reduction (SVR35) of 49.8% for the combination arm vs 28% for the control arm at week 24. Post-hoc analysis from the phase 3 SENTRY trial suggests SVR35 may predict overall survival (OS); new data from the…
-
NIANCE Expands Beyond Products into a Global Beauty & Longevity Ecosystem
ZURICH, June 3, 2026 /PRNewswire/ — Swiss luxury beauty brand NIANCE is entering a new phase of growth with the launch of an integrated beauty and longevity ecosystem combining skincare, supplementation, diagnostics, treatments, recovery, and wellness experiences. Known for its science-backed approach to healthy aging, NIANCE has spent the past decade developing products to support beauty…
-
Bluejay Diagnostics Announces Closing of Up to $23.7 Million Private Placement Priced At-The-Market Under Nasdaq Rules
June 05, 2026 20:13 ET | Source: Bluejay Diagnostics, Inc. $8.5 million upfront with up to approximately $15.2 million of potential additional gross proceeds upon the exercise in full of warrants Net proceeds anticipated to extend cash runway into first quarter of 2027, beyond expected FDA submission; if warrants are exercised in full for cash,…
-
Anderson Diagnostics and MAHE Launch Groundbreaking Centre of Excellence in Reproductive Genomics
MAHE-Anderson COE to Revolutionise Women’s Healthcare Diagnostics Manipal, Karnataka, India; Chennai, Tamil Nadu, India Anderson Diagnostics & Labs, Chennai, in a landmark partnership with Manipal Academy of Higher Education (MAHE), today announced the formal launch of the MAHE-Anderson Centre of Excellence (COE) in Reproductive Genomics. Inaugural Ceremony of Centre of Excellence in Reproductive Genomics…
Latest News
About the Author
We increase the awareness of millions of users through our news networks. We are one of the most trusted news networks in the world.